Indo US Bio-Tech Ltd

INDOUS

Watchlist

AI Mode

‌

Market Cap

₹ 251 Cr

P/E

14.83

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Indo Us Bio-Tech Limited is a leading seed company in India, focused on crop research, breeding, and seed production.

Originally established as Pollucid Bio-Tech in 2004, the company underwent several name changes before becoming a public limited company in 2018.

The company operates seed processing plants in Gujarat, utilizing modern technologies to process, store, and pack seeds.

Indo Us Bio-Tech boasts a robust network of over 2500 distributors and dealers across India, emphasizing its growth and market presence.

The company is involved in extensive R&D, developing a diverse range of germplasm varieties and marketing products under multiple brand names.

Sector

FMCG

Industry

Biotechnology

Market Cap

251 Cr

Volatility

Low Risk

P/E Ratio

14.8

Industry P/E

74.2

PEG Ratio

0.3

P/B Ratio

2.9

52W High

374.95

52W Low

110.30

Sales CAGR

24.81%

27.54%

21.17%

10Y

—

Profit CAGR

3.27%

45.91%

45.04%

10Y

—

ROE

TTM

19.49%

16.22%

16.43%

10Y

16.58%

ROCE

TTM

16.44%

18.06%

17.87%

10Y

18.76%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
REMUS	755.65	890 Cr	30.81	3.48	0.10	10.92	16.89	7.42
INDOUS	125.05	251 Cr	14.83	2.89	0.00	19.49	16.44	14.40
VIVOBIOT	29.45	66 Cr	16.02	0.69	0.00	4.22	7.95	2.48
SHREEGANES	0.61	24 Cr	—	0.38	0.00	0.26	0.26	0.25
TRABI	2.72	22 Cr	—	2.34	0.00	-17.64	-3.52	-1.13
VANTABIO	20.49	15 Cr	—	1.01	0.00	-23.51	-15.08	-7.97
SCAGRO	21.75	13 Cr	31.52	4.46	0.00	14.14	16.25	4.15

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	19	16	22	38	25	22	24	33	31	31
Expenses	16	13	18	33	21	17	18	29	25	27
Operating Profit	2.99	2.59	4.24	5.21	3.69	5.12	5.54	4.57	5.47	4.17
OPM %	15.62	16.38	19.18	13.75	14.93	23.09	23.51	13.69	17.78	13.52
Other Income	0.03	0.00	0.08	0.29	0.03	0.02	0.02	0.12	0.00	0.03
Interest	0.37	0.41	0.37	0.73	0.33	0.52	0.38	0.26	0.45	0.42
Depreciation	0.20	0.21	0.19	0.39	0.20	0.18	0.16	0.56	0.20	0.21
Profit Before Tax	2.45	1.97	3.75	4.38	3.19	4.45	5.02	3.88	4.82	3.56
Tax %	2.86	15.23	1.87	3.88	0.63	2.02	-0.80	4.90	2.49	3.09
Net Profit	2.37	1.67	3.68	4.21	3.17	4.36	5.05	3.68	4.70	3.45
EPS in Rs	1.19	0.83	1.84	2.10	1.58	2.16	2.52	1.86	2.35	1.72

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Sales	40	40	50
Expenses	36	35	43
Operating Profit	3.94	5.33	6.77
OPM %	9.91	13.28	13.51
Other Income	0.01	0.04	0.18
Interest	0.85	1.17	1.18
Depreciation	0.23	0.27	0.46
Profit Before Tax	2.86	3.93	5.31
Tax %	11.49	-24.71	4.67
Net Profit	2.53	4.90	5.06
EPS in Rs	—	—	—
Dividend Payout %	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Equity Capital	6.07	6.07	9.17
Reserves	10	15	29
Borrowings	7.87	12	13
Other Liabilities	10	11	4.27
Total Liabilities	35	44	56
Fixed Assets	1.41	2.37	5.55
CWIP	1.28	1.99	2.32
Investments	0.00	0.00	0.00
Other Assets	32	39	48
Total Assets	35	44	56

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Cash from Operating Activity	-0.84	0.16	2.70
Cash from Investing Activity	-0.57	-1.78	-5.44
Cash from Financing Activity	1.53	1.55	2.65
Net Cash Flow	0.12	-0.07	-0.09

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Aug 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	70.17%	70.17%	70.17%	70.17%	70.17%	70.17%	70.17%	70.17%	70.17%	70.17%	70.17%	70.17%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	29.83%	29.83%	29.83%	29.83%	29.83%	29.83%	29.83%	29.83%	29.82%	29.83%	29.83%	29.83%
Total Shareholders	235	251	318	1,227	1,166	1,133	838	971	2,828	2,780	3,112	4,130

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	19	16	22	38	25	22	24	33	31	31
Expenses	16	13	18	33	21	17	18	29	25	27
Operating Profit	2.99	2.59	4.24	5.21	3.69	5.12	5.54	4.57	5.47	4.17
OPM %	15.62	16.38	19.18	13.75	14.93	23.09	23.51	13.69	17.78	13.52
Other Income	0.03	0.00	0.08	0.29	0.03	0.02	0.02	0.12	0.00	0.03
Interest	0.37	0.41	0.37	0.73	0.33	0.52	0.38	0.26	0.45	0.42
Depreciation	0.20	0.21	0.19	0.39	0.20	0.18	0.16	0.56	0.20	0.21
Profit Before Tax	2.45	1.97	3.75	4.38	3.19	4.45	5.02	3.88	4.82	3.56
Tax %	2.86	15.23	1.87	3.88	0.63	2.02	-0.80	4.90	2.49	3.09
Net Profit	2.37	1.67	3.68	4.21	3.17	4.36	5.05	3.68	4.70	3.45
EPS in Rs	1.19	0.83	1.84	2.10	1.58	2.16	2.52	1.86	2.35	1.72

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Sales	40	40	50
Expenses	36	35	43
Operating Profit	3.94	5.33	6.77
OPM %	9.91	13.28	13.51
Other Income	0.01	0.04	0.18
Interest	0.85	1.17	1.18
Depreciation	0.23	0.27	0.46
Profit Before Tax	2.86	3.93	5.31
Tax %	11.49	-24.71	4.67
Net Profit	2.53	4.90	5.06
EPS in Rs	—	—	—
Dividend Payout %	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Equity Capital	6.07	6.07	9.17
Reserves	10	15	29
Borrowings	7.87	12	13
Other Liabilities	10	11	4.27
Total Liabilities	35	44	56
Fixed Assets	1.41	2.37	5.55
CWIP	1.28	1.99	2.32
Investments	0.00	0.00	0.00
Other Assets	32	39	48
Total Assets	35	44	56

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Cash from Operating Activity	-0.84	0.16	2.70
Cash from Investing Activity	-0.57	-1.78	-5.44
Cash from Financing Activity	1.53	1.55	2.65
Net Cash Flow	0.12	-0.07	-0.09

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
REMUS	755.65	890 Cr	30.81	3.48	0.10	10.92	16.89	7.42
INDOUS	125.05	251 Cr	14.83	2.89	0.00	19.49	16.44	14.40
VIVOBIOT	29.45	66 Cr	16.02	0.69	0.00	4.22	7.95	2.48
SHREEGANES	0.61	24 Cr	—	0.38	0.00	0.26	0.26	0.25
TRABI	2.72	22 Cr	—	2.34	0.00	-17.64	-3.52	-1.13
VANTABIO	20.49	15 Cr	—	1.01	0.00	-23.51	-15.08	-7.97
SCAGRO	21.75	13 Cr	31.52	4.46	0.00	14.14	16.25	4.15

Overview

Detailed Summary

Indo Us Bio-Tech Limited is a leading seed company in India, focused on crop research, breeding, and seed production.

Originally established as Pollucid Bio-Tech in 2004, the company underwent several name changes before becoming a public limited company in 2018.

The company operates seed processing plants in Gujarat, utilizing modern technologies to process, store, and pack seeds.

Indo Us Bio-Tech boasts a robust network of over 2500 distributors and dealers across India, emphasizing its growth and market presence.

The company is involved in extensive R&D, developing a diverse range of germplasm varieties and marketing products under multiple brand names.

Sector

FMCG

Industry

Biotechnology

Market Cap

251 Cr

Volatility

Low Risk

P/E Ratio

14.8

Industry P/E

74.2

PEG Ratio

0.3

P/B Ratio

2.9

52W High

374.95

52W Low

110.30

Sales CAGR

24.81%

27.54%

21.17%

10Y

—

Profit CAGR

3.27%

45.91%

45.04%

10Y

—

ROE

TTM

19.49%

16.22%

16.43%

10Y

16.58%

ROCE

TTM

16.44%

18.06%

17.87%

10Y

18.76%